(19)
(11) EP 2 555 785 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
13.07.2016 Bulletin 2016/28

(45) Mention of the grant of the patent:
06.04.2016 Bulletin 2016/14

(21) Application number: 11721384.3

(22) Date of filing: 07.04.2011
(51) International Patent Classification (IPC): 
A61K 35/74(2015.01)
 A61P 11/00(2006.01)
(86) International application number:
PCT/IT2011/000104
(87) International publication number:
WO 2011/125086 (13.10.2011 Gazette 2011/41)

(54)

USE OF STREPTOCOCCUS SALIVARIUS IN THE TREATMENT OF CHRONIC INFECTIONS OF THE RESPIRATORY TRACT

VERWENDUNG VON STREPTOCOCCUS SALIVARIUS ZUR BEHANDLUNG VON ATEMWEGSINFEKTIONEN

UTILISATION DE STREPTOCOCCUS SALIVARIUS POUR LE TRAITEMENT D'INFECTIONS DE LA VOIE RESPIRATOIRE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 07.04.2010 IT RM20100163

(43) Date of publication of application:
13.02.2013 Bulletin 2013/07

(73) Proprietor: D.M.G. Italia Srl
00071 Pomezia (RM) (IT)

(72) Inventors:
  • STEFANI, Stefania
    I-95124 Catania (CT) (IT)
  • TIBERI, Licia
    I-00040 Pomezia (RM) (IT)
  • SANTAGATI, Maria.
    I-95124 Catania (CT) (IT)

(74) Representative: Sarpi, Maurizio 
Studio Ferrario srl Via Collina 36
00187 Roma
00187 Roma (IT)


(56) References cited: : 
WO-A1-2004/072272
   
  • WALLS TONY ET AL: "Bacteriocin-like inhibitory substance (BLIS) production by the normal flora of the nasopharynx: potential to protect against otitis media?", JOURNAL OF MEDICAL MICROBIOLOGY SEP 2003 LNKD- PUBMED:12909662, vol. 52, no. Pt 9, September 2003 (2003-09), pages 829-833, XP002603368, ISSN: 0022-2615
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).